Emergency management of anaphylaxis in children and young people: New guidance from the Resuscitation Council (UK)

Archives of Disease in Childhood: Education and Practice Edition

Volumn 94, Issue 4, 2009, Pages 97-101

  Tse, Y ^a   Rylance, George ^a  

^a ROYAL VICTORIA INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; AMINOPHYLLINE; ANTIHISTAMINIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; HYPERTENSIVE FACTOR; IPRATROPIUM BROMIDE; MAGNESIUM; SALBUTAMOL;

ANAPHYLAXIS; BRONCHOSPASM; CHILD; CLINICAL FEATURE; DISEASE PREDISPOSITION; DISEASE SEVERITY; DRUG ABSORPTION; DRUG DOSE TITRATION; DRUG SAFETY; EMERGENCY CARE; HOSPITAL DISCHARGE; HUMAN; IDIOPATHIC DISEASE; MEDICAL EDUCATION; PATIENT EDUCATION; PLASMA; PRACTICE GUIDELINE; PRIORITY JOURNAL; RESUSCITATION; REVIEW; TREATMENT FAILURE; TREATMENT OUTCOME; TREATMENT RESPONSE;

EID: 69249158192     PISSN: 17430585     EISSN: 17430593     Source Type: Journal    
DOI: None     Document Type: Review

References (41)

1. Johansson SG, Bieber T, Dahl R, et al. Revised nomenclature for allergy for global use: report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. J Allergy Clin Immunol 2004;113(5):832-836 (Pubitemid 38608590)
2. Gupta R, Sheikh A, Strachan DP, et al. Time trends in allergic disorders in the UK. Thorax 2007;62(1):91-96
3. Gupta R, Sheikh A, Strachan D, et al. Increasing hospital admissions for systemic allergic disorders in England: analysis of national admissions data. BMJ 2003;327:1142-1143 (Pubitemid 37421810)
4. Peng MM, Jick H. A population-based study of the incidence, cause, and severity of anaphylaxis in the United Kingdom. Arch Intern Med 2004;164(3):317-319 (Pubitemid 38176473)
5. Pumphrey RS. Fatal anaphylaxis in the UK, 1992-2001. Novartis Found Symp 2004;257:116-28; discussion 128-32, 157-60, 276-285
6. Greenberger PA. Idiopathic anaphylaxis. Immunol Allergy Clin North Am 2007;27(2):273-293, vii-viii.
7. The International Collaborative Study of Severe Anaphylaxis. Risk of anaphylaxis in a hospital population in relation to the use of various drugs: an international study. Pharmacoepidemiol Drug Saf 2003;12(3):195-202.
8. Lack G, Fox D, Northstone K, et al. Factors associated with the development of peanut allergy in childhood. N Engl J Med 2003;348:977-985 (Pubitemid 36302242)
9. Bohlke K, Davis RL, Marcy SM, et al. Risk of anaphylaxis after vaccination of children and adolescents. Pediatrics 2003;112(4):815-820 (Pubitemid 37248689)
10. Brown SG. Clinical features and severity grading of anaphylaxis. J Allergy Clin Immunol 2004;114(2):371-376
11. Sampson HA, Munoz-Furlong A, Campbell RL, et al. Second symposium on the definition and management of anaphylaxis: summary report--second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. Ann Emerg Med 2006;47(4):373-380
12. Pumphrey R. Anaphylaxis: can we tell who is at risk of a fatal reaction? Curr Opin Allergy Clin Immunol 2004;4(4):285-290
13. Brown SG. Cardiovascular aspects of anaphylaxis: implications for treatment and diagnosis. Curr Opin Allergy Clin Immunol 2005;5(4):359-364 (Pubitemid 41017652)
14. McLean-Tooke AP, Bethune CA, Fay AC, et al. Adrenaline in the treatment of anaphylaxis: what is the evidence? BMJ 2003;327(7427):1332-1335
15. Pumphrey RS. Lessons for management of anaphylaxis from a study of fatal reactions. Clin Exp Allergy 2000;30(8):1144-1150
16. Sampson HA, Mendelson L, Rosen JP. Fatal and near-fatal anaphylactic reactions to food in children and adolescents. N Engl J Med 1992;327:380-384
17. TenBrook JA Jr, Wolf MP, Hoffman SN, et al. Should beta-blockers be given to patients with heart disease and peanut-induced anaphylaxis? A decision analysis. J Allergy Clin Immunol 2004;113(5):977-982
18. Thomas M, Crawford I. Glucagon infusion in refractory anaphylactic shock in patients on beta-blockers. Emerg Med J 2005;22(4):272-273 (Pubitemid 40520707)
19. Simons FE, Gu X, Simons KJ. Epinephrine absorption in adults: intramuscular versus subcutaneous injection. J Allergy Clin Immunol 2001;108(5):871-873 (Pubitemid 33096224)
20. Simons FE, Roberts JR, Gu X, et al. Epinephrine absorption in children with a history of anaphylaxis. J Allergy Clin Immunol 1998;101(1 Pt 1):33-37 (Pubitemid 28112878)
21. Simons FE, Chan ES, Gu X, et al. Epinephrine for the out-of-hospital (first-aid) treatment of anaphylaxis in infants: is the ampule/syringe/needle method practical? J Allergy Clin Immunol 2001;108(6):1040-1044
22. Brown SG, Blackman KE, Stenlake V, et al. Insect sting anaphylaxis; prospective evaluation of treatment with intravenous adrenaline and volume resuscitation. Emerg Med J 2004;21(2):149-154 (Pubitemid 38344625)
23. Glaeser PW, Hellmich TR, Szewczuga D, et al. Five-year experience in prehospital intraosseous infusions in children and adults. Ann Emerg Med 1993;22(7):1119-1124 (Pubitemid 23191023)
24. Visscher PK, Vetter RS, Camazine S. Removing bee stings. Lancet 1996;348(9023):301-302
25. Sheikh A, Ten Broek V, Brown SG, et al. H(1)-antihistamines for the treatment of anaphylaxis: Cochrane systematic review. Allergy 2007;62(8):830-837
26. Smith M, Iqbal S, Elliott TM, et al. Corticosteroids for hospitalised children with acute asthma. Cochrane Database Syst Rev 2003;(2):CD002886.
27. Schwartz LB. Diagnostic value of tryptase in anaphylaxis and mastocytosis. Immunol Allergy Clin North Am 2006;26(3):451-463
28. Brown SG, Blackman KE, Heddle RJ. Can serum mast cell tryptase help diagnose anaphylaxis? Emerg Med Australas 2004;16(2):120-124
29. Caughey GH. Tryptase genetics and anaphylaxis. J Allergy Clin Immunol 2006;117(6):1411-1414
30. Edston E, van Hage-Hamsten M. Mast cell tryptase and hemolysis after trauma. Forensic Sci Int 2003;131:8-13. (Pubitemid 36043912)
31. Tole JW, Lieberman P. Biphasic anaphylaxis: review of incidence, clinical predictors, and observation recommendations. Immunol Allergy Clin North Am 2007;27(2):309-26, viii. (Pubitemid 46686990)
32. Lee JM, Greenes DS. Biphasic anaphylactic reactions in pediatrics. Pediatrics 2000;106:762-766
33. Poon M, Reid C. Oral corticosteroids in acute urticaria. Emerg Med J 2004;21(1):76-77
34. Sicherer SH, Simons FE. Quandaries in prescribing an emergency action plan and self-injectable epinephrine for first-aid management of anaphylaxis in the community. J Allergy Clin Immunol 2005;115(3):575-583
35. Abay J, Unsworth DJ. Appropriate prescription of epinephrine remains the best available treatment. Arch Dis Child 2001;85:510. (Pubitemid 33116497)
36. Sicherer SH, Forman JA, Noone SA. Use assessment of self-administered epinephrine among food-allergic children. Pediatrics 2000;105:359-362
37. Gold MS, Sainsbury R. First aid anaphylaxis management in children prescribed an epinephrine autoinjector device. J Allergy Clin Immunol 2000;106:171-176 (Pubitemid 30482868)
38. Kapoor S, Roberts G, Bynoe Y, et al. Influence of a multidisciplinary paediatric allergy clinic on parental knowledge and rate of subsequent allergic reactions. Allergy 2004;59(2):185. (Pubitemid 38250774)
39. Vickers DW, Maynard L, Ewan PW. Management of children with potential anaphylactic reactions in the community: a training package and proposal for good practice. Clin Exp Allergy 1997;27:898-903. (Pubitemid 27359855)
40. Alrasbi M, Sheikh A. Comparison of international guidelines for the emergency medical management of anaphylaxis. Allergy 2007;62:838-841 (Pubitemid 47037863)
41. Muraro A, Roberts G, Clark A, et al. EAACI Task Force on Anaphylaxis in Children. The management of anaphylaxis in childhood: position paper of the European Academy of Allergology and Clinical Immunology. Allergy 2007;62:857-871